Moreover, the presence of mutations does depend on the Ki-67 index; however, it does not depend on the patients’ age, lymph node metastasis, ER, PR or HER2 status and histopathological malignancy level. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.